April 26, 2018

Micreos winner Finals Ideas from Europe 2018

Dutch biotech Micreos ‘sustainable alternative to antibiotics’ chosen as Europe’s most relevant innovation at the finals of the EUs Ideas from Europe competition in the Hall of Knights on the 24th of April.

View Pitch

Read Press Release

Mark Offerhaus, CEO of the Dutch biotechnology company Micreos, presents Staphefekt against MRSA in Amsterdam on Nov.6, 2014

Use keywords to search the news archieve

Filter:

2022

Micreos Pharmaceuticals announces success of its XZ.700 technology in selectively eliminating Staphylococcus aureus pathogen without triggering resistance

Staphylococcus aureus cells undergoing lysis by the action of XZ.700 PRESS RELEASE ...

Micreos Pharmaceuticals welcomes Trine Ahlgreen and Carsten Edwards to its Executive team to accelerate its next phase of development

PRESS RELEASE Zug, Switzerland, 5-April 2022 — Micreos Pharmaceuticals today a ...

Micreos appoints Joost Goderie as CFO and member of the Board of Directors

PRESS RELEASE The Hague, The Netherlands, January 28, 2022 - Micreos announced that it has ap ...